Structures by: Huang H. M.
Total: 13
C33H40N2O4
C33H40N2O4
Org. Biomol. Chem. (2017)
a=11.4817(6)Å b=11.8623(7)Å c=12.3995(7)Å
α=76.664(5)° β=63.649(6)° γ=70.861(5)°
2(C33H34F6N2O2),C2.81H6.52,C3.19H7.48
2(C33H34F6N2O2),C2.81H6.52,C3.19H7.48
Org. Biomol. Chem. (2017)
a=11.6196(7)Å b=13.8475(8)Å c=21.0449(12)Å
α=89.100(5)° β=83.969(5)° γ=83.670(5)°
2(C18H18N2O)
2(C18H18N2O)
Chemical communications (Cambridge, England) (2018) 54, 72 10160-10163
a=22.8586(15)Å b=5.0654(4)Å c=13.0500(8)Å
α=90° β=98.008(6)° γ=90°
C19H20N2O
C19H20N2O
Chemical communications (Cambridge, England) (2018) 54, 72 10160-10163
a=41.133(3)Å b=13.3359(14)Å c=11.1564(8)Å
α=90° β=90° γ=90°
C19H18N2O3
C19H18N2O3
Chemical communications (Cambridge, England) (2018) 54, 72 10160-10163
a=11.0010(11)Å b=6.9737(7)Å c=20.129(2)Å
α=90° β=93.637(9)° γ=90°
(2<i>R</i>)-<i>N</i>-[5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-yl]-2- (cinnamoylamino)propanamide
C20H17ClN4O2S
Acta Crystallographica Section E (2008) 64, 10 o2006
a=6.6324(15)Å b=8.575(2)Å c=34.367(8)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>)-2-Cinnamoylamino-<i>N</i>-[5-(4-methoxyphenyl) -1,3,4-thiadiazol-2-yl]propanamide
C21H20N4O3S
Acta Crystallographica Section E (2008) 64, 10 o1887
a=9.082(3)Å b=9.849(3)Å c=13.644(4)Å
α=79.587(4)° β=83.253(4)° γ=65.458(4)°
C27H22O3
C27H22O3
Acta Crystallographica, Section C: Crystal Structure Communications (2004) 60, 10 o709-o710
a=9.609(3)Å b=15.799(4)Å c=13.426(4)Å
α=90.00° β=98.189(5)° γ=90.00°
2-Benzoylamino-<i>N</i>-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]ethanamide
C17H13BrN4O2S
Acta Crystallographica Section E (2009) 65, 2 o325
a=4.020(4)Å b=13.706(9)Å c=16.210(5)Å
α=113.334(17)° β=94.018(19)° γ=92.78(2)°
Diammonium aqua(ethylenediaminetetraacetato)iron(II) trihydrate
2(H4N),C10H14FeN22,3(H2O)
Acta Crystallographica Section E (2009) 65, 1 m87-m88
a=8.7615(10)Å b=8.9485(10)Å c=13.4742(15)Å
α=80.3090(10)° β=81.0050(10)° γ=68.7790(10)°
<i>catena</i>-Poly[[bis(nitrato-κ^2^<i>O</i>,<i>O</i>)copper(II)]-μ- 2,2'-(ethane-1,2-diyldithio)di-1,3,4-thiadiazole-κ^2^N^4^:N^4'^]
C6H6CuN6O6S4
Acta Crystallographica Section E (2009) 65, 1 m80-m81
a=5.2143(8)Å b=7.0214(10)Å c=10.6476(16)Å
α=105.144(2)° β=100.000(2)° γ=93.958(2)°
(2<i>R</i>,3<i>R</i>)-<i>N</i>-(4-Chlorophenyl)-2,3-dihydroxy-<i>N</i>'-(5- phenyl-1,3,4-thiadiazol-2-yl)succinamide
C18H15ClN4O4S
Acta Crystallographica Section E (2010) 66, 4 o765
a=41.381(3)Å b=5.1744(5)Å c=8.7442(9)Å
α=90.00° β=98.3150(10)° γ=90.00°
SSZ-45
C88H168N16O400Si200
Chemistry of Materials (2014) 26, 13 3909
a=13.7195(1)Å b=35.2245(6)Å c=22.1362(1)Å
α=90° β=90° γ=90°